At the last check on Friday, Oscar Health Inc.’s (NYSE:OSCR) stock was up $0.06, moving up 0.77 percent to $7.16. The average number of shares traded per day over the past five days has been 1,641,570 shares. 2 times new highs have been achieved over the past 5 days. In the last twenty days, the average volume was 1,980,573, while in the previous 50 days, it was 4,058,015.
Since last month, OSCR stock rose 12.68%. Shares of the company fell to $5.88 on 04/27/23, the lowest level in the past month. A 52-week high of $8.08 was reached on 05/23/23 after having rallying from a 52-week low of $2.05. Since the beginning of this year, OSCR’s stock price has risen by 190.85% or $4.73, and marked a new high 29 times. However, the stock has declined by -11.45% since its 52-week high.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
OSCR stock investors should be aware that Oscar Health Inc. (OSCR) stock had its last reported insider trading activity 81 days ago on Mar 06. Blackley Richard Scott, the Chief Transformation Officer of the company, disposed of 30,764 shares for $4.88 on Mar 06. It resulted in a $150,156 divestment by the insider. Quane Alessandrea C. sold 12,473 shares at an average price of $4.88 on Mar 06. The insider now owns 188,328 shares following the transaction. On Mar 02, Interim CFO Sankaran Sid sold 110,396 shares at $4.75 apiece. The transaction was valued at $524,436.
According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.32, and the total debt-to-equity ratio was 0.32. In the year ended March 30, operating margins totaled -12.30%. Based on annual data, OSCR earned -$610.08 million in gross profit and brought in $3.96 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -49.60%. Return on equity (ROE) for the past 12 months was -55.10%.
In Oscar Health Inc.’s quarter-end financial report for March 30, it reported total debt of $298.19 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. OSCR’s revenue rose 33.81% to $995.13 million during the quarter, while net income inched up to $1.47 billion. While analysts expected Oscar Health Inc. to report -$0.05 quarterly earnings, the actual figure was -$0.18 per share. During the quarter, the company generated -$27.55 million in EBITDA. The value of shareholders’ equity is $218.35 million.
This quick technical analysis looks at Oscar Health Inc.’s (OSCR) price momentum. With a historical volatility rate of 51.78%, the RSI 9-day stood at 54.61% on 25 May.
At present, OSCR shares trade +6.84% above its 20-day simple moving average and +192.28% percent above its 100-day simple moving average. However, the stock is currently trading approximately +109.01% above its SMA50 and +10.96% above its SMA200.
Stochastic coefficient K was 55.06% and Stochastic coefficient D was 59.82%, while ATR was 0.42. Given the Stochastic reading of 58.86% for the 14-day period, the RSI (14) reading has been calculated as 56.63%. As of today, the MACD Oscillator reading stands at -0.07, while the 14-day reading stands at -0.01.
Oscar Health Inc. (OSCR) has been rated Hold by analysts. According to 0 brokerage firms, OSCR is a sell, and 3 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 0 analysts rate Oscar Health Inc. stock as buy, with 2 recommending it as overweight.
With a median target price of $7.00, the current consensus forecast for the stock is $5.40 – $9.00. Based on these forecasts, analysts predict Oscar Health Inc. (OSCR) will achieve an average price target of $7.07.